Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
5.94
+0.12 (2.06%)
At close: Aug 26, 2026, 4:00 PM EDT
5.93
-0.01 (-0.17%)
After-hours: Aug 26, 2026, 7:24 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $15.6 million as of August 26, 2026. Its market cap has increased by 85.69% in one year.
Market Cap
15.60M
Enterprise Value
-13.11M
1-Year Change
85.69%
Ranking
Category
Stock Price
$5.94
ChartMarket Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $15.60M, a decrease of -40.69%. That is a compound annual growth rate of -6.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 15.60M | 194.30% |
| Dec 31, 2025 | 5.30M | -18.46% |
| Dec 31, 2024 | 6.50M | 182.61% |
| Dec 29, 2023 | 2.30M | -60.34% |
| Dec 30, 2022 | 5.80M | -89.66% |
| Dec 31, 2021 | 56.10M | 131.82% |
| Dec 31, 2020 | 24.20M | -2.81% |
| Dec 31, 2019 | 24.90M | -25.89% |
| Dec 31, 2018 | 33.60M | 27.76% |
| Jul 30, 2018 | 26.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 15.88M |
| Lisata Therapeutics | 15.86M |
| Akari Therapeutics, | 15.67M |
| Intensity Therapeutics | 15.67M |
| Passage Bio | 15.54M |
| NeuroSense Therapeutics | 15.16M |
| Vyome Holdings | 15.09M |
| BioVie | 15.01M |